Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5399561 | 1.00 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3806768 | 1.00 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7057032 | 1.00 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL4411839 | 0.98 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL2363817 | 0.95 | OPRM1 (0.34) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL2363335 | 0.95 | OPRM1 (0.34) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL2363490 | 0.93 | OPRM1 (0.35) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL2733647 | 0.90 | ALDH1A1 (0.34) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3655351 | 0.87 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3060057 | 0.87 | KDM4E (0.33) | KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2183228-A1 | CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 | Vitae Pharmaceuticals, Inc. (US) | 2010-05-12 | — | — | EP | claimed |
| US-7605107-B2 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-10-20 | — | — | US | claimed |
| US-7538066-B2 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2009-05-26 | — | — | US | claimed |
| WO-2009017664-A1 | CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1 | VITAE PHARMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | claimed |
| US-20070082811-A1 | Method of preparing a hydrotreating catalyst on a support containing a rare earth metal | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-04-12 | — | — | US | claimed |
| US-20070072765-A1 | Method of preparing a supported hydrotreating catalyst | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2007-03-29 | — | — | US | claimed |
| EP-3053944-B1 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR | SHINETSU CHEMICAL CO (JP) | 2021-10-06 | — | — | EP | disclosed |
| US-10472377-B2 | Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-11-12 | — | — | US | disclosed |
| EP-2531480-B1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-01-16 | — | — | EP | disclosed |
| US-20170275305-A1 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR | SHINETSU CHEMICAL CO (JP) | 2017-09-28 | — | — | US | disclosed |
| US-20170275305-A1 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR | SHINETSU CHEMICAL CO (JP) | 2017-09-28 | — | — | US | disclosed |
| US-9708350-B2 | Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9708350-B2 | Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| EP-2531480-A1 | DEHYDROGENATION PROCESS | ExxonMobil Chemical Patents Inc. (US) | 2012-12-12 | — | — | EP | disclosed |
| US-20120302798-A1 | Dehydrogenation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-11-29 | — | — | US | disclosed |
| US-20120271077-A1 | Dehydrogenation Process | EXXONMOBILE CHEMICAL PATENTS INC. (US) | 2012-10-25 | — | — | US | disclosed |
| WO-2012050665-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2011096992-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096997-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011096994-A1 | DEHYDROGENATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275305-A1 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR | ADH1A, ADH1C, AP3M1 | KDM4E 2409/4885MEN1 3250/4885KMT2A 1405/4885 |
| US-10472377-B2 | Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator | ADH1A, ADH1C, AP3M1 | KDM4E 2409/4885MEN1 3250/4885KMT2A 1405/4885 |
| US-20120271077-A1 | Dehydrogenation Process | ADH5, ADH1A, ADH1C | KDM4E 2118/4885MEN1 3747/4885KMT2A 2800/4885 |
| US-20120302798-A1 | Dehydrogenation Process | NDUFV1, NDUFV2, MAFG | KDM4E 537/4885MEN1 1335/4885KMT2A 582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.